Literature DB >> 7198991

Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.

C Spyraki, H C Fibiger.   

Abstract

The effects of acute and chronic administration of desipramine (DMI) on a number of behaviors thought to be dependent on central dopaminergic (DA) systems were examined in the rat. Chronic but not acute administration of DMI potentiated the locomotor response to d-amphetamine within a narrow dosage range. The potentiation of the amphetamine response was observed up to 5 days after cessation of chronic DMI but had nearly returned to baseline by 10 days. Neither amphetamine- nor apomorphine-induced stereotypy was affected by chronic DMI. Chronic administration of iprindole but not fluoxetine potentiated amphetamine-induced locomotor activity. Chronic DMI administration did not affect the concentration or distribution of [3H]d-amphetamine in the brain. Furthermore, residual anticholinergic effects of DMI did not appear to be responsible for the potentiated amphetamine response. Chronic administration of DMI did not significantly influence the hypomotility induced by low doses of apomorphine. The increased locomotor activity and rearing produced by moderate doses of apomorphine were significantly increased by chronic DMI administration. The results suggest that chronic DMI may produce supersensitivity of postsynaptic receptors in the mesolimbic DA projection, a system that has been associated with the mediation of amphetamine- and apomorphine-induced increases in locomotor activity. There was no evidence for subsensitivity of presynaptic DA receptors after DMI. The findings are discussed with reference to the possible role of central DA neurons in the antidepressant mechanism of action of the tricyclic compounds.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198991     DOI: 10.1016/0014-2999(81)90531-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  44 in total

1.  Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.

Authors:  A Towell; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Failure of memantine to "reverse" quinpirole-induced hypomotility.

Authors:  Francesca Demontis; Gino Serra
Journal:  World J Psychiatry       Date:  2016-06-22

3.  Lack of persistent effects of ketamine in rodent models of depression.

Authors:  Piotr Popik; Tomasz Kos; Magdalena Sowa-Kućma; Gabriel Nowak
Journal:  Psychopharmacology (Berl)       Date:  2008-05-07       Impact factor: 4.530

4.  Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1989

Review 5.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

6.  Roxindole, a potential antidepressant. I. Effect on the dopamine system.

Authors:  J Maj; K Kolodziejczyk; Z Rogóz; G Skuza
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

7.  The effect of amitriptyline treatment on the growth hormone response to apomorphine.

Authors:  P J Cowen; L E Braddock; B Gosden
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Effects of acute and chronic desipramine treatment on somatostatin receptors in brain.

Authors:  E G Gheorvassaki; K Thermos; G Liapakis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Electroconvulsive treatment attenuates behavioral response to SKF 38393 in reserpine-treated mice.

Authors:  X Z Hao; A A Mathé; J M Mathé; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Paraganglionic cell response to chronic imipramine and handling stress: an ultrastructural study.

Authors:  J C Folan; O Johansson; C Heym
Journal:  J Neural Transm Gen Sect       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.